Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 296,565	$ 26,868
Accounts receivable:
Trade	48,002	31,515
Other, net	15,387	17,538
Inventories:
Product inventories	58,203	34,962
Materials and supplies	72,644	69,974
Other current assets	24,059	33,295
Total current assets	514,860	214,152
Investments	44,107	33,897
Non-current restricted cash and cash equivalents	1,183	1,177
Property, plants, equipment and mine development, net	2,714,439	2,694,119
Operating lease right-of-use assets	8,834	7,544
Other non-current assets	25,932	30,171
Total assets	3,309,355	2,981,060
Current liabilities:
Accounts payable and accrued liabilities	87,909	88,957
Accrued payroll and related benefits	25,915	22,834
Accrued taxes	8,324	6,312
Current debt	35,384	33,617
Finance leases	7,770	8,169
Accrued reclamation and closure costs	8,836	13,748
Accrued interest	14,372	14,316
Other current liabilities	4,452	9,885
Total current liabilities	192,962	197,838
Accrued reclamation and closure costs	119,326	111,162
Long-term debt including finance leases	521,568	508,927
Deferred tax liabilities	155,121	110,266
Other non-current liabilities	10,345	13,353
Total liabilities	999,322	941,546
Commitments and contingencies (Notes 4, 7, 8, and 11)
STOCKHOLDERS' EQUITY
Series B preferred stock, $0.25 par value, 157,756 shares issued and outstanding, liquidation preference - $7,889	39	39
Common stock, $0.25 par value, authorized 1,250,000,000 shares; issued June 30, 2025 - 671,843,297 shares and December 31, 2024 - 640,547,918 shares	167,872	160,052
Capital surplus	2,594,492	2,418,149
Accumulated deficit	(411,975)	(493,529)
Accumulated other comprehensive loss, net	(4,579)	(10,266)
Less treasury stock, at cost; June 30, 2025 - 8,768,372 and December 31, 2024 - 8,813,127 shares issued and held in treasury	(35,816)	(34,931)
Total stockholders' equity	2,310,033	2,039,514
Total liabilities and stockholders' equity	$ 3,309,355	$ 2,981,060